Minipress Oral Capsule 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Minipress: Oral capsule (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2836.JPG
Prazosin 1mg Cap
Mylan Institutional LLC formerly UDL Laboratories Inc
Pill Identification: MYLAN 1101 MYLAN 1101 
Drug Image file DrugItem_14305.JPG
Prazosin 1mg Cap
Teva Pharmaceuticals USA Inc
Pill Identification: 93 4067 93 4067 
Drug Image file DrugItem_12442.JPG
Prazosin 1mg Cap
PD-RX Pharmaceuticals
Pill Identification: MYLAN 1101 MYLAN 1101 
Drug Image file DrugItem_7090.JPG
Prazosin 1mg Cap
Lederle Pharmaceutical Div American Cyanamid Co
Pill Identification: Lederle P69 Lederle P69 
Drug Image file DrugItem_2355.JPG
Minipress 1mg Cap
Pfizer US Pharmaceuticals
Pill Identification: MINIPRESS PFIZER 431 
Drug Image file DrugItem_138.JPG
Prazosin 1mg Cap
Ivax Pharmaceuticals Inc a Division of Teva USA
Pill Identification: LOGO 4067 LOGO 4067 
Drug Image file DrugItem_7091.JPG
Prazosin 1mg Cap
Mylan Pharmaceuticals Inc
Pill Identification: MYLAN 1101 MYLAN 1101 

What is this Medicine?

PRAZOSIN (PRA zoe sin) is an antihypertensive. It works by relaxing the blood vessels. It is used to treat high blood pressure.

In-Depth Information

Minipress 1mg Capsule

NDC: 000694310
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypertension

Sometimes used for but not FDA approved for the following conditions:
Raynaud's Phenomenon, Hypertensive Urgency, Heart Failure, Posttraumatic Stress Disorder (PTSD), Benign Prostatic Hyperplasia (BPH)

Storage Information
Store below 86 degrees F
Minipress 1mg Capsule
Drug Image file DrugItem_2355.JPG
Pfizer US Pharmaceuticals
Pill Identification: MINIPRESS PFIZER 431 
Shape: capsule
Color: white

Reported Side Effects for Minipress 1mg Capsule

Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Uncontrolled Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Priapism Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Rash Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Increased Urination Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Engorgement With Blood Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Postural Low Blood Pressure Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Blurred Vision Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: EARLY
Stuffy Nose Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Balance Problems Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.9%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
5.3%*
Severity: MODERATE
Onset: EARLY
Weakness Incidence:
6.5%*
Severity: MILD
Onset: EARLY
Tired Incidence:
6.9%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
7.6%*
Severity: MILD
Onset: EARLY
Headache Incidence:
7.8%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
10.3%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Minipress 1mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Minipress 1mg Capsule(Prazosin Hydrochloride)
Alcohol and Antihypertensives(Prazosin Hydrochloride)
Although an interaction is possible, Ethanol (alchohol) and Antihypertensive Agents (drugs used to reduce high blood pressure) may be used together. Ethanol or alchohol-containing beverages may increase the effects of Antihypertensive Agents on your blood pressure. If the blood pressure drops too low while taking Ethanol and Antihypertensive Agents, you may become dizzy or feel faint. To limit this interaction, avoid alcohol-containing beverages while taking medicines to lower your blood pressure. Do not stand or sit up too quickly. Contact your prescriber if you have dizziness which does not go away.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Minipress

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5